ASP Isotopes (NASDAQ:ASPI) COO Robert Ainscow Sells 8,438 Shares

ASP Isotopes Inc. (NASDAQ:ASPI) COO Robert Ainscow sold 8,438 shares of the firm’s stock in a transaction on Monday, June 8th. The shares were sold at an average price of $7.00, for a total value of $59,066.00. Following the completion of the sale, the chief operating officer owned 2,281,879 shares of the company’s stock, valued at approximately $15,973,153. This trade represents a 0.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Ainscow also recently made the following trade(s):

• On Thursday, April 16th, Robert Ainscow sold 22,500 shares of ASP Isotopes stock. The shares were sold at an average price of $5.21, for a total value of $117,225.00.

ASP Isotopes Price Performance

Shares of NASDAQ:ASPI traded down $0.55 during midday trading on Wednesday, reaching $5.85. The company’s stock had a trading volume of 3,997,678 shares, compared to its average volume of 6,216,526. The business’s fifty day simple moving average is $5.65 and its 200-day simple moving average is $5.84. The company has a debt-to-equity ratio of 0.69, a current ratio of 4.39 and a quick ratio of 4.37. The company has a market capitalization of $736.52 million, a P/E ratio of -2.81 and a beta of 3.42. ASP Isotopes Inc. has a fifty-two week low of $3.92 and a fifty-two week high of $14.49.

ASP Isotopes (NASDAQ:ASPI) last announced its quarterly earnings data on Wednesday, May 20th. The company reported ($0.22) EPS for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.06. The firm had revenue of $8.36 million during the quarter, compared to analyst estimates of $3.68 million. ASP Isotopes had a negative return on equity of 112.46% and a negative net margin of 644.40%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on ASPI. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Friday, March 27th. Canaccord Genuity Group reiterated a “buy” rating and issued a $11.00 price objective on shares of ASP Isotopes in a research report on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $13.00.

Hedge Funds Weigh In On ASP Isotopes

Institutional investors have recently modified their holdings of the stock. Rovida Investment Management Ltd grew its position in shares of ASP Isotopes by 45.5% during the 3rd quarter. Rovida Investment Management Ltd now owns 3,200,000 shares of the company’s stock worth $30,688,000 after buying an additional 1,000,000 shares during the period. Caprock Group LLC acquired a new position in shares of ASP Isotopes during the 3rd quarter worth about $2,747,000. SPX Gestao de Recursos Ltda acquired a new position in shares of ASP Isotopes during the 3rd quarter worth about $1,054,000. Rathbones Group PLC grew its position in shares of ASP Isotopes by 68.6% during the 4th quarter. Rathbones Group PLC now owns 399,599 shares of the company’s stock worth $2,138,000 after buying an additional 162,535 shares during the period. Finally, Tudor Investment Corp ET AL grew its position in shares of ASP Isotopes by 37.5% during the 3rd quarter. Tudor Investment Corp ET AL now owns 460,685 shares of the company’s stock worth $4,432,000 after buying an additional 125,687 shares during the period. 16.80% of the stock is currently owned by institutional investors and hedge funds.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.